Adalimumab could counter hyper-inflammation seen in severe coronavirus cases

A commonly used arthritis drug is to be trialled with care home residents who have Covid, after it was observed that those taking it for their joint pains were less likely to end up in hospital with the virus.

Older people in care homes, who often have some degree of dementia, tend not to do well in hospital, where they become more confused and may pick up infections. The trial will break new ground by giving the drug to people at care homes, where they can be supervised and monitored afterwards by doctors and nurses.

Continue reading…

You May Also Like

Steve Bannon banned by Twitter for calling for Fauci beheading

Former Trump adviser falls foul of Twitter rules with ‘heads on pikes’…

Rose Matafeo: ‘I feel a massive sense of guilt for making a romcom’

With her smash hit Starstruck exploring fairytale romance and what happens next,…

American XL bully dog ban may be ineffective in short term, UK experts warn

Limited police resources and court backlogs of owners seeking exemptions for their…

Met detective sacked for racism has been reinstated and sent on leadership course

Police discipline panel dismissed Neil Buckmaster in 2021 over ‘offensive and utterly…